Executive Director, Global Program Lead, Oncology (Pumitamig)
Core
Leading the development strategy and execution for Pumitamig, a PD-L1xVEGFF bispecific antibody for solid tumors, in collaboration with BioNTech.
Role type
Executive Director, Global Program Leader (Oncology)
Builds
Innovative medicines for solid tumors
Domain
Oncology / Biopharmaceuticals
Deliverable
production ML models | product features | dashboards & analysis | research | client delivery | infrastructure | physical/clinical work
Required skills
drug development process expertise, matrix team leadership, oncology biology, regulatory health authority expectations, clinical trial design, commercialization strategy, risk assessment, cross-functional collaboration, strategic planning, data-driven decision making
Preferred skills
lung cancer experience, translational medicine, clinical pharmacology, exposure-response relationships, dose selection, business development due diligence
Technologies
bispecific antibodies, PD-L1, VEGF
Responsibilities
Create vision and design integrated development plans for assets; Engage cross-company expertise and advisory groups to define strategies; Analyze progress and assert problem-solving for data-driven decision making; Ensure process and output meet program standards; Engage senior leaders and stakeholders for alignment; Participate in regulatory filings and orphan drug designation; Engage with Health Authorities in clinical trial design; Lead team in developing program and commercialization strategies; Build relationships with external stakeholders; Understand clinical trial operational complexities; Integrate commercialization inputs into late program strategy; Contribute to forecasts, investment scenarios, and valuations; Support brand strategy and KOL plans; Coach and mentor team members.
Seniority
Executive, strategic leadership & matrix management